You are here

KRONİK BÖBREK YETERSİZLİĞİ OLGUSUNDA OSTEOMALASİ: RENAL OSTEODİSTROFİYE Mİ BAĞLI YA DA BAŞKA SEBEPLER ARAYALIM MI?

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Osteomalacia in a patient with ehronic renal failure: Caused by renal osteodvstrophy or is there any need to research other disorders? A 56 years ol d female patient was admitted to our elinic with the complaints of weakness and diffuse pain along the last year. Threc years ago, ehronic renal failure secondary to ehronic pyelonephritis that was complicated with renal oste-odystrophy were diagnosed and aetive oral vitamin D was given. The patient's physical exanıi-nation was unremarkabie. Laboratory examination revealed inereased serum alkaline phospha-tase, gamma-glutamyl transferasc and liver transaminases, together with moderate azotemia, hypophosphatemia, proîeinuria and glucosuria. Hypophosphotemia and glucosuria without hyperglycemia and osteomalasia could indicate Fanconi syndromc. On the other hand, liver bi-opsy was pcıformed due to the elevaled serum cnzyme levels, which showed findings of pri-mary biiiary cirrhosis (PBC). There may be more than onc reason for osteomalacia in the same patient. In PBC, malabsorption of vitamin D secondary to cholestasis İs the most common cau-se of osteomalacia followed by other rare conditions such as abııormal 25-hydroxylation of vitamin D due to hepatoeyte degeneration and renal tubular losses due to Fanconi syudrome as-sociatcd with autoimmunc and/or tubulointerstitial nephritis secondary to PBC. In our patient, both cirrhosis and osteomalacia could lıave itıcreased the serum alkaline phosphatase level.
Abstract (Original Language): 
EI1İ aitı yaşında kadm hasta kliniğimize son bir yıldır ortaya çıkan halsizlik ve yaygın vücut ağrıları şikayetleri ile başvurdu. Üç yıl önce kronik pyelonefrit sonrası gelişen kronik böbrek yetersizliği vc renal osteodistrofi tanıları konulmuş, oral aktif vitamin D tedavisi başlanmış. Hastanın fizik muayenesinde kayda değer bir bulgu saptanmadı. Laboratuvar incelemelerinde, yüksek serum alkaleıı fosfataz, gamma glutamil transferaz ve karaciğer tıansaminaz değerleri ile hipofosfatcmi,proteinlin ve glikozüri bulundu. Kronik böbrek yetersizliğine rağmen hipo-fosfatemi saptanması ve hiperglisemi olmadığı halde glikozüri bulunması sonucu Fanconi sendromu düşünüldü. Karaciğer biyopsisinde primer biliyer sirozla (PBS) uyumlu bulgular saptandı. Osteonıaiasi, aynı hastada birden çok sebeple ortaya çıkabilir. Primer biliyer siroza ikincil gelişen osteonıaiasi, öncelikle intrahepatik koiestaz ile barsaklardan D vitamini enıili-minin bozulması ile, daha nadir olarak ise karaciğer doku hasarı ile 25 hidroksi D vitamini sentezinin azalması ve birlikte olabilecek otoimmun veya tubulointersitisyel nefrite bağlı ortaya çıkan Fanconi sendromu sonucu gelişebilir. Hastamızdaki serum alkalen fosfataz artışı, hem PBS ile ortaya çıkan İntrahepatik koiestaz ve hem de osteomalasi sonucu gelişmiş olabilir.
252-255

REFERENCES

References: 

1. Chesney RW, Novello AC: Defects of renal tubular trans-port. Edt. Massry SG, Glassock RJ. Textbook of Nephro-logy 2nd ediiion, volume 1, Williams & Wilkins, Baltimore, (1989), 453-7.
2. Danieisson A, Lorentzon R, Larsson SE: Intestinal ab-sorption and 25-hydroxyIation of vitamin D in patients with primary biiiary cirrhosis. Scand J Gastroenterol; 17:349(1982).
3. Davidson BKS, Haslock I: Osteomalacia secondary to renal tubular acidosis masquerading as primary biiiary cirrhosis. Rlıeiimatol; 39: 1428 (2000).
4. Drezner MK: Metabolic Bone Disease. Kelley WN, Text-book of Internal Medicine, 3rd Eddition, Lippincott-Ra-ven, Philadelphia (1997); 2258-62.
5. Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitimin W, Wo[fe HJ: Osteoporosis İn primary biiiary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroen-terology; 83:97(1982).
6. Wagonfeld JB, Bolt M, Boyer JL, Nemchausky BA, Horst JV, Rosenberg İH: Comparİson of vitamin D and 25-hydroxyvitamin D in the therapy of primary biiiary cirrhosis. Lancet, 2: 391 (1976).

Thank you for copying data from http://www.arastirmax.com